Semaglutide

Semaglutide is a synthetic 31-amino-acid peptide, a modified analogue of the human GLP-1 sequence carrying a C18 fatty diacid side chain, classified as a GLP-1 receptor agonist. It is supplied as a lyophilized powder for laboratory research use.

This page collects every semaglutide-containing item in the catalog: the multi-dose lyophilized vial and the semaglutide / BPC-157 combination vial. Available as lyophilized vials.

Lyophilized peptide is stable at ambient temperature in transit. Store sealed vials refrigerated and protected from light; once in solution, keep refrigerated and refer to the certificate of analysis supplied with the lot.

Every lot is third-party tested at greater than 99% purity and supplied with a certificate of analysis. Research use only, not for human consumption.

Related research compounds: tirzepatide, retatrutide and BPC-157. The full group is in Incretin & Glucagon Receptor Ligands.